Prosecution Insights
Last updated: October 02, 2026

VERADERMICS INCORPORATED

Technology area: Biotechnology & Pharmaceuticals

41 pending office actions • 3 art units • 5 examiners • 0 of 41 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

VERADERMICS INCORPORATED is currently navigating 41 pending office actions within the Biotechnology & Pharmaceuticals technology area. This concentration of 41 pending actions suggests a focused but intensive period of patent prosecution for the company. The high volume of actions relative to the number of examiners indicates a significant workload per individual assigned to these cases, which may impact the speed of the examination process.

The portfolio is being examined by only 5 distinct examiners across 3 distinct art units. This is a notably high concentration, as the 41 pending office actions are funnelled through just 5 distinct examiners. Such a narrow distribution across 3 distinct art units suggests that the company's technology is highly specialized and falls under the jurisdiction of a very limited group of patent office specialists, making the understanding of these specific examiners' tendencies crucial.

HENLEY III, RAYMOND J is the busiest examiner, managing 37 busiest examiner pending actions. This means that HENLEY III, RAYMOND J is responsible for the vast majority of the 41 total pending office actions for the company. Practitioners should note that the outcome of this company's prosecution efforts is heavily dependent on the decisions and tendencies of this single examiner, who handles nearly all of the active matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

41
Total Pending OAs
30
Non-Final OAs
11
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (12%)
29
Medium (71%)
7
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (10%)
§112 only2 (5%)
Double-patenting only5 (12%)
Double-patenting + other25 (61%)
Multi-statute (no §101)5 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

37
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
7% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

410 h
Manual time on pending OAs
82 h
Time saved (low, 20%)
144 h
Time saved (mid, 35%)
3.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HENLEY III, RAYMOND J 37 83.5% +2.3%
ALLEN, ROBERT F 1 73.2% +61.9%
HEITMEIER, KENDALL NICOLE 1 65.9% +41.0%
AHMED, TASNIM M 1 81.1% +5.2%
DARB, HAMZA A. 1 74.4% +30.9%

Quick Wins (34)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19329494 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 8d overdue
19245208 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 4d overdue
19215242 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 33d
19572691 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19572667 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19569963 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19570012 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19569918 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 28d overdue
19258817 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 28d overdue
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 24d overdue
19267464 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18283685 PERILESIONAL TREATMENT OF SKIN CONDITIONS DARB, HAMZA A. 15d
18659756 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY ALLEN, ROBERT F —
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE —

Top Art Units

Art UnitApps
1629 37
3783 2
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19572691 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Mar 19, 2026
19572667 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Non-Final OA — Pending Mar 19, 2026
19569963 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Mar 17, 2026
19570012 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Mar 17, 2026
19569918 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Mar 17, 2026
19546276 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Non-Final OA — Pending Feb 20, 2026
19542655 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 17, 2026
19539689 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 13, 2026
19538689 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 12, 2026
19538745 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 12, 2026
19444686 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 09, 2026
19443936 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 08, 2026
19442911 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 07, 2026
19442899 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 07, 2026
19442979 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 07, 2026
19442974 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Jan 07, 2026
19441484 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 06, 2026
19436869 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Dec 30, 2025
19430093 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Dec 22, 2025
19420555 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Dec 15, 2025
19402812 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112Other Non-Final OA — Pending Nov 26, 2025
19329494 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Final Rejection 8d overdue Pending Sep 15, 2025
19329476 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Final Rejection — Pending Sep 15, 2025
19328077 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Sep 12, 2025
19308124 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Final Rejection — Pending Aug 22, 2025
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA 24d overdue Pending Jul 11, 2025
19267464 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA — Pending Jul 11, 2025
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112 Non-Final OA 28d overdue Pending Jul 03, 2025
19258817 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA 28d overdue Pending Jul 02, 2025
19253703 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Jun 27, 2025
19245208 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA 4d overdue Pending Jun 20, 2025
19241304 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Jun 17, 2025
19236933 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Jun 12, 2025
19230047 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Jun 05, 2025
19230007 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Jun 05, 2025
19230054 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Jun 05, 2025
19215242 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112 Non-Final OA 33d Pending May 21, 2025
18659756 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY ALLEN, ROBERT F — §103§112DP Non-Final OA — Pending May 09, 2024
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE 3781 §102§103§112 Non-Final OA — Pending Feb 23, 2024
18563118 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY AHMED, TASNIM M 3783 §103 Final Rejection — Pending Nov 21, 2023
18283685 PERILESIONAL TREATMENT OF SKIN CONDITIONS DARB, HAMZA A. 3783 §103 Final Rejection 15d Pending Sep 22, 2023

Managing VERADERMICS INCORPORATED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month